Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTCO2P9 is a pseudogene derived from the mitochondrial MT-CO2 gene, which encodes cytochrome c oxidase subunit II. Pseudogenes are DNA sequences that have lost their protein-coding ability through evolution, typically due to mutations that disrupt their normal function[5]. While the parent gene MT-CO2 is essential for mitochondrial electron transport and ATP synthesis as part of complex IV of the respiratory chain[1][4], MTCO2P9 itself is non-coding and does not produce a functional protein. Mitochondrial pseudogenes like MTCO2P9 represent sequences of mitochondrial DNA that have been incorporated into the nuclear genome but are themselves noncoding[5]. Unlike its functional counterpart MT-CO2, which plays a crucial role in cellular energy metabolism and is associated with various mitochondrial diseases[4], MTCO2P9 serves no known biological function and is not considered a therapeutic target. The pseudogene is cataloged in genomic databases with the accession numbers 107075267 (NCBI Gene) and ENSG00000249386 (Ensembl)[3][8].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CO2 pseudogene 9 (MTCO2P9).